These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10439880)

  • 21. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis.
    Fan Y; Zhang AM; Xiao YB; Weng YG; Hetzer R
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):192-9. PubMed ID: 21075642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycometabolic status and acute myocardial infarction: has the time come for glucose-insulin-(potassium) therapy?
    Wong V; Cheung NW; Boyages SC
    Intern Med J; 2003; 33(9-10):443-9. PubMed ID: 14511197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.
    Pache J; Kastrati A; Mehilli J; Bollwein H; Ndrepepa G; Schühlen H; Martinoff S; Seyfarth M; Nekolla S; Dirschinger J; Schwaiger M; Schömig A
    Am Heart J; 2004 Jul; 148(1):e3. PubMed ID: 15215812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-insulin-potassium echocardiography detects improved segmental myocardial function and viable tissue shortly after acute myocardial infarction.
    Klein LJ; van Campen LC; Sieswerda GT; Kamp O; Visser CA; Visser FC
    J Am Soc Echocardiogr; 2006 Jun; 19(6):763-71. PubMed ID: 16762754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-insulin-potassium for acute myocardial infarction: remarkable results from a new prospective, randomized trial.
    Apstein CS
    Circulation; 1998 Nov; 98(21):2223-6. PubMed ID: 9826307
    [No Abstract]   [Full Text] [Related]  

  • 26. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials.
    Fath-Ordoubadi F; Beatt KJ
    Circulation; 1997 Aug; 96(4):1152-6. PubMed ID: 9286943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions.
    Lazar HL; Zhang X; Rivers S; Bernard S; Shemin RJ
    Ann Thorac Surg; 1995 Aug; 60(2):411-6. PubMed ID: 7646105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of GIK (glucose-insulin-potassium) on stress-induced myocardial ischaemia.
    Di Marco S; Boldrini B; Conti U; Marcucci G; Morgantini C; Ferrannini E; Natali A
    Clin Sci (Lond); 2010 Apr; 119(1):37-44. PubMed ID: 20001969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy with insulin in cardiac surgery: controversies and possible solutions.
    Doenst T; Bothe W; Beyersdorf F
    Ann Thorac Surg; 2003 Feb; 75(2):S721-8. PubMed ID: 12607718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction.
    Bedetti G; Pizzi C; Gabrieli L; Varga A; Pasanisi E; Bugiardini R; Picano E
    Int J Cardiol; 2005 Jul; 102(2):255-8. PubMed ID: 15982493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Apstein CS
    JAMA; 2005 Jun; 293(21):2596-7; author reply 2598. PubMed ID: 15928276
    [No Abstract]   [Full Text] [Related]  

  • 32. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Dey J; Blonde L; Burshell A; Bolton P; Richard A
    JAMA; 2005 Jun; 293(21):2597-8; author reply 2598. PubMed ID: 15928277
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Cobb LA; Killip T; Lambrew CT; MacLeod BA; Rackley CE; Selker HP; Zalenski RJ
    JAMA; 2005 Jun; 293(21):2597; author reply 2598. PubMed ID: 15928278
    [No Abstract]   [Full Text] [Related]  

  • 34. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.
    van der Horst IC; Zijlstra F; van 't Hof AW; Doggen CJ; de Boer MJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gans RO; Bilo HJ;
    J Am Coll Cardiol; 2003 Sep; 42(5):784-91. PubMed ID: 12957421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions.
    Lazar HL
    J Card Surg; 1994 May; 9(3 Suppl):474-8. PubMed ID: 8069039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction.
    Türel B; Gemici K; Baran I; Yeşilbursa D; Güllülü S; Aydinlar A; Serdar A; Kazazoğlu AR; Kumbay E; Cordan J
    Anadolu Kardiyol Derg; 2005 Jun; 5(2):90-4. PubMed ID: 15939681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of baboons in studies of acute myocardial infarction and effects of infusions of glucose, insulin and potassium (GIK).
    Bruyneel K; Opie LH
    Acta Med Scand Suppl; 1976; 587():65-9. PubMed ID: 1062133
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization.
    Yazici M; Demircan S; Durna K; Yasar E; Acar Z; Sahin M
    Am J Cardiol; 2005 Dec; 96(11):1517-20. PubMed ID: 16310433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple principles of clinical trials remain powerful.
    Califf RM
    JAMA; 2005 Jan; 293(4):489-91. PubMed ID: 15671435
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucose, insulin and potassium (GIK) during reperfusion mediates improved myocardial bioenergetics.
    Angelos MG; Murray HN; Gorsline RT; Klawitter PF
    Resuscitation; 2002 Dec; 55(3):329-36. PubMed ID: 12458070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.